| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 1004 |
| 1 | ASPIRIN | 814 |
| 2 | ASPIRIN 325 MG | 799 |
| 3 | ASPIRIN 81 MG | 799 |
| 4 | METFORMIN | 739 |
| 5 | METFORMIN ER 500 MG | 632 |
| 6 | METFORMIN ER 750 MG | 632 |
| 7 | AMLODIPINE | 595 |
| 8 | DAPAGLIFLOZIN | 580 |
| 9 | ERGOCALCIFEROL | 576 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FINERENONE | 335 | 0.1015 |
| 1 | VOCLOSPORIN | 380 | 0.0388 |
| 2 | SPARSENTAN | 253 | 0.0374 |
| 3 | TOLVAPTAN | 320 | 0.0214 |
| 4 | ERGOCALCIFEROL | 576 | 0.0194 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 118 | 0.0141 |
| 6 | EPLERENONE | 164 | 0.0125 |
| 7 | DAPAGLIFLOZIN | 580 | 0.0096 |
| 8 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 79 | 0.0088 |
| 9 | REMDESIVIR | 117 | 0.0088 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1452 |
| 1 | Loop Diuretic [EPC] | 1257 |
| 2 | Corticosteroid [EPC] | 1256 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 1194 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 844 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 819 |
| 6 | Aldosterone Antagonist [EPC] | 714 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 711 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 710 |
| 9 | Proton Pump Inhibitor [EPC] | 680 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin V2 Receptor Antagonist [EPC] | 320 | 0.0214 |
| 1 | Provitamin D2 Compound [EPC] | 576 | 0.0194 |
| 2 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 3 | Cyclooxygenase Inhibitor [EPC] | 1 | 0.0122 |
| 4 | Progestin Antagonist [EPC] | 48 | 0.0101 |
| 5 | Vasoconstrictor [EPC] | 3 | 0.0100 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 117 | 0.0088 |
| 7 | Cortisol Synthesis Inhibitor [EPC] | 6 | 0.0079 |
| 8 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 9 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 25 | 0.0074 |